Regulations and Regulatory Issues

Advancements in blockchain technology point toward an evolving landscape where transparency, security protocols, and regulatory compliance integrate into standard cannabis operations.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.

ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.

The recent release of the Senate's draft for the 2024 Farm Bill could reshape how this versatile crop is cultivated, processed, and regulated.

This month’s GMP Collective webinar focused on how collaboration within the industry can lead to overall growth and success.

The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.

The hemp products were seized from the ABC licensed locations for being out compliance with the state's new regulations.

The second part of this column will take a look at specific examples in the public domain of elemental contamination of cannabis consumer products, which shows that other elements are worthy of consideration and should be a part of the regulatory framework.

Inconsistent testing is a significant issue in the cannabis industry, contributing to fears about potency inflation and product safety. However, adopting cGMP compliance offers a clear solution by implementing standardized testing protocols, comprehensive batch testing, and rigorous third-party verification.

The new hemp regulations, limiting THC levels in products, took effect in September.

The ruling states that federal law does not block the ban on certain cannabinoid products in the state.

This report is the first one published since the state’s legal market began.

The temporary restraining order would prevent the enforcement of these regulations while the lawsuit is being litigated.

As we approach a pivotal election, the cannabis industry finds itself at a crossroads. If federal legalization passes, cannabis could be reclassified from a Schedule I to a Schedule III drug. This shift would remove many barriers for businesses and consumers, opening the door to broader acceptance and regulation. However, this potential change also stirs up concerns among those opposed to cannabis, who fear its legalization could lead to unchecked risks for public health and safety.

The bill would amend the definition of hemp to raise the threshold of delta-9 THC to 1% from 0.3%.

The Cannabinoid Safety and Regulation Act would establish a regulatory regime for products that contain hemp cannabinoids.

On September 24th, 2024, the U.S. Hemp Roundtable, a group of California hemp farmers and businesses filed a lawsuit against the regulations.

The DHSS will focus enforcement efforts on misbranded intoxicating cannabinoid products.

The U.S. Hemp Roundtable submitted comments to California’s Office of Administrative Law (OAL) on September 16th, urging the agency to overrule emergency regulations proposed by Governor Gavin Newsom and the California Department of Public Health (CDPH).

The Attorney General's office says that non-alcoholic beverages with hemp-derived tetrahydrocannabinol (THC) with concentrations of delta-9 THC of no more than 0.3% are legal in South Carolina, assuming you can verify they meet this threshold.

The bill regulates the sale and distribution of products containing synthetic THC, though some challenges remain to be resolved.

According to Sunmed, the regulations effectively make 95% of the retailer’s inventory illegal, depriving consumers of wellness products they trust and rely on to support their health, as well as putting retailers at risk of closure.

The lawsuit challenges Emergency Rules issued by the agency on June 2024 that would establish a licensing program for retailers and suppliers of hemp-derived cannabinoid products.

The regulations would ban any hemp-derived food, beverage and dietary products from having any THC levels and impose an age restriction of 21 to purchase these products.